Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement.
about
Microneedle delivery of trivalent influenza vaccine to the skin induces long-term cross-protection.Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.New technologies for influenza vaccines.Local response to microneedle-based influenza immunization in the skin.Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.Microneedles for drug and vaccine deliveryIntradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.Cancer vaccination by electro-gene-transfer.Affordable inactivated poliovirus vaccine: strategies and progress.Fluzone® Intradermal Quadrivalent Influenza Vaccine.Fluzone® High-Dose Influenza Vaccine.Immunogenicity, safety and tolerability of intradermal influenza vaccines.Microfabrication for Drug DeliveryVaccination for seasonal influenza in patients with cancer: recommendations of the Italian Society of Medical Oncology (AIOM).Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device.Acceptance and safety of the intradermal influenza vaccine among the elderly in Italy: an on-field national study.Influenza vaccination in healthcare workers: A comprehensive critical appraisal of the literature.
P2860
Q30385423-19E442DB-8F7C-4446-8ABC-E48E67E326D2Q30407851-83476BDC-5908-4078-B28A-000E638EACF6Q30411859-0A9DFBAB-AC37-4484-8EEA-70959F8B8D33Q35826992-C12BA3AB-7F80-4103-8BC4-D6635359180CQ35874111-A9689CDC-0E81-4ECF-A5ED-EDF310455F66Q36164749-93180378-2B4A-4595-A57F-93413A03CFF7Q36223598-E9F62E7F-F6D5-4B17-9239-1373F2BF6B7FQ36887912-1FFDC088-D31D-4F94-9E5B-55623943528CQ37375954-A1979A70-AB91-4F8F-808B-CBC5028B1EA6Q37469592-17417E8B-D703-43CC-A696-B87437A455B7Q38143182-5A04CF52-193E-4385-BAD2-853D002BB8AEQ38260382-DB58E29F-7D59-4067-98B1-266F8976AA69Q38908471-86D0B7AA-D9CD-479C-8307-1C943B0EE8ABQ38998621-97962F1F-35D7-41D6-9B9F-9A42B8220C02Q39366321-55B3B66A-5367-46D9-9723-DB07B90133FCQ41006286-E741DCD7-4786-40CD-98D5-81E009EE5C81Q42224597-152953B9-5A90-42A4-AE78-127066E51C85Q43630592-48760462-81B1-4020-BCF0-FAFFDC595ACFQ45785920-54FFE3E9-61D4-4552-B69A-11C486A7ED13Q47749933-D79ED8ED-750F-41F4-A18A-3E3A74591DCF
P2860
Intradermal influenza vaccine and new devices: a promising chance for vaccine improvement.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intradermal influenza vaccine ...... hance for vaccine improvement.
@en
Intradermal influenza vaccine ...... hance for vaccine improvement.
@nl
type
label
Intradermal influenza vaccine ...... hance for vaccine improvement.
@en
Intradermal influenza vaccine ...... hance for vaccine improvement.
@nl
prefLabel
Intradermal influenza vaccine ...... hance for vaccine improvement.
@en
Intradermal influenza vaccine ...... hance for vaccine improvement.
@nl
P2093
P2860
P1476
Intradermal influenza vaccine ...... hance for vaccine improvement.
@en
P2093
Filippo Ansaldi
Giancarlo Icardi
Paolo Durando
P2860
P304
P356
10.1517/14712598.2011.557658
P407
P577
2011-03-01T00:00:00Z